FOXNEWS America Reports With John Roberts Sandra Smith August 10, 2021 18:50:00
Her2- metastatic breast cancer. kisqali is approved for both pre- and postmenopausal women, and has extended lives in multiple clinical trials. kisqali is a pill thats significantly more effective at delaying disease progression versus a nonsteroidal aromatase inhibitor or fulvestrant alone. kisqali can cause lung problems, or an abnormal heartbeat, which can lead to death. it can cause serious skin reactions, liver problems, and low white blood cell counts that may result in severe infections. ...
Breast Cancer Aromatase Inhibitor Disease Progression Versus Breathing Problems Liver Problems Chest Pain
Source: archive.org